A detailed history of Ing Groep Nv transactions in Dexcom Inc stock. As of the latest transaction made, Ing Groep Nv holds 89,577 shares of DXCM stock, worth $6.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
89,577
Holding current value
$6.03 Million
% of portfolio
0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $9.88 Million - $12.6 Million
89,577 New
89,577 $10.2 Million
Q3 2023

Oct 27, 2023

SELL
$86.06 - $137.93 $2.84 Million - $4.54 Million
-32,946 Reduced 85.43%
5,617 $524,000
Q2 2023

Aug 07, 2023

BUY
$112.47 - $130.98 $4.06 Million - $4.73 Million
36,137 Added 1489.57%
38,563 $4.96 Million
Q1 2023

May 09, 2023

SELL
$104.0 - $122.92 $9.19 Million - $10.9 Million
-88,348 Reduced 97.33%
2,426 $281,000
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $7.71 Million - $11.1 Million
90,774 New
90,774 $10.3 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $1.58 Million - $2.18 Million
-16,768 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $901,557 - $1.13 Million
6,942 Added 70.65%
16,768 $9 Million
Q3 2021

Nov 02, 2021

BUY
$106.71 - $143.18 $18,994 - $25,486
178 Added 1.84%
9,826 $5.37 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $265,647 - $354,010
3,280 Added 51.51%
9,648 $4.12 Million
Q1 2021

May 12, 2021

SELL
$84.79 - $104.74 $84 - $104
-1 Reduced 0.02%
6,368 $2.29 Million
Q4 2020

Feb 11, 2021

BUY
$78.0 - $104.5 $331,500 - $444,125
4,250 Added 200.57%
6,369 $2.36 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $127,792 - $151,127
1,338 Added 171.32%
2,119 $874,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $48,953 - $82,270
781 New
781 $317,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.